Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 14/20 | 0.49 |
| ▸ | F7 | P08709 | 1/20 | 0.49 |
| ▸ | F3 | P13726 | 1/20 | 0.49 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 13/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.43 |
| ▸ | F10 | P00742 | 2/20 | 0.42 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30929420 | 0.91 | F2 (0.46) | F2F7F3P2RX7PRSS1 | |
| SCHEMBL30929391 | 0.90 | F2 (0.46) | F2F7F3PRSS1PRSS2 | |
| SCHEMBL30929396 | 0.87 | F2 (0.51) | F2F7F3PRSS1PRSS2 | |
| SCHEMBL30929392 | 0.86 | F2 (0.49) | F2F7F3PRSS1PRSS2 | |
| SCHEMBL30929418 | 0.86 | F2 (0.55) | F2F7F3P2RX7PRSS1 | |
| SCHEMBL30929439 | 0.86 | F2 (0.47) | F2F7F3P2RX7PRSS1 | |
| SCHEMBL30929454 | 0.85 | F2 (0.48) | F2F7F3P2RX7PRSS1 | |
| SCHEMBL30929463 | 0.85 | F2 (0.47) | F2F7F3PRSS1PRSS2 | |
| SCHEMBL30929445 | 0.83 | F2 (0.48) | F2F7F3P2RX7PRSS1 | |
| SCHEMBL30929431 | 0.81 | BRD4 (0.48) | F2F7F3P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626891-A1 | FUSED PYRIMIDINES AS MASP-2 INHIBITORS | Omeros Corporation (US) | 2025-10-08 | — | — | EP | disclosed |
| WO-2024118840-A1 | FUSED PYRIMIDINES AS MASP-2 INHIBITORS | OMEROS CORPORATION (US) | 2024-06-06 | — | — | WO | disclosed |